Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)

NCT07488754 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
High-Grade Glioma (WHO III-IV)
Glioblastoma (GBM)

Interventions

RADIATION: Radiation: Local, targeted therapy with alpha emitter [225Ac]Ac-DOTA-SP (TAT)

Sponsor

Medical University of Warsaw